Wow now you have competition among the suppliers. Love free enterprise. So what the verdict....its an open race with risks to Express Scripts. Smart move on part of GILD. Choice of 600 pills versus 80. Love it!
Potential for ES all this will backfire. Its all be played out by how much muscle and control on the provider community and consumers. Certainly not a sure win.